Anti-Cd105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-Gd2 Antibody Immunotherapy of Neuroblastoma With Activated Natural Killer Cells
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-3358
Full Text
Open PDFAbstract
Available in full text
Date
May 8, 2019
Authors
Publisher
American Association for Cancer Research (AACR)